HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 247 filers reported holding HAEMONETICS CORP in Q4 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,419,877 | +5.3% | 49,340 | +0.0% | 0.40% | +4.9% |
| Q2 2023 | $4,199,105 | -24.9% | 49,320 | -27.0% | 0.39% | -19.4% |
| Q1 2023 | $5,593,900 | +20.8% | 67,600 | +14.8% | 0.48% | +22.5% |
| Q4 2022 | $4,632,485 | +649.6% | 58,900 | +753.6% | 0.39% | +598.2% |
| Q2 2020 | $618,000 | -83.6% | 6,900 | -81.7% | 0.06% | -87.6% |
| Q1 2020 | $3,763,000 | -15.1% | 37,760 | -2.1% | 0.45% | +17.7% |
| Q4 2019 | $4,431,000 | +2.2% | 38,560 | +12.2% | 0.38% | +1.6% |
| Q3 2019 | $4,334,000 | +422.2% | 34,360 | +398.0% | 0.38% | +362.2% |
| Q2 2019 | $830,000 | +69.4% | 6,900 | +23.2% | 0.08% | +86.4% |
| Q1 2019 | $490,000 | -80.2% | 5,600 | -77.3% | 0.04% | -85.0% |
| Q4 2018 | $2,471,000 | +26.8% | 24,700 | +45.3% | 0.29% | +14.9% |
| Q3 2018 | $1,948,000 | +27.7% | 17,000 | 0.0% | 0.26% | +36.4% |
| Q2 2018 | $1,525,000 | +15.8% | 17,000 | -5.6% | 0.19% | +2.2% |
| Q1 2018 | $1,317,000 | -1.4% | 18,000 | -21.7% | 0.18% | -15.3% |
| Q4 2017 | $1,336,000 | – | 23,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |